Baxalta Said to Quit Ariad Takeover Talks

Baxalta Inc., the drugmaker fending off a $30 billion takeover offer from Shire Plc, has abandoned its pursuit of Ariad Pharmaceuticals Inc. after negotiations broke down over price, people with knowledge of the matter said. Bloomberg's Vonnie Quinn reports on "Bloomberg Markets." (Source: Bloomberg)

Rabobank Sees BOJ, PBOC Throwing Liquidity Into Markets
03:25 - Rabobank Financial Markets Research Asia Head Michael Every discusses his outlook for the markets and talks about his investment thoughts. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • ICICI Bank Bad Debt Ratio Rose to 8%
  • Nissan Sees SUVs Driving Sales
  • Starbucks Spends $1.3 Billion in China